Th17 cells are refractory to senescence and retain robust antitumor activity after long-term ex vivo expansion
Jacob S. Bowers(Medical University of South Carolina), Chrystal M. Paulos(Emory University)
Cited by 69
Related Papers
Identification of Chimeric Antigen Receptors That Mediate Constitutive or Inducible Proliferation of T Cells
|Cancer Immunology Research|2015|332
Th17 Cells in Cancer: The Ultimate Identity Crisis
|Frontiers in Immunology|2014|327
Ex vivo blockade of PI3K gamma or delta signaling enhances the antitumor potency of adoptively transferred CD8 <sup>+</sup> T cells
|European Journal of Immunology|2020|64